Raptiva (efalizumab)
Audience: Dermatological healthcare professionals, patients [Posted 02/19/2009] FDA issued a Public Health Advisory to notify healthcare professionals of three confirmed, and one possible report of progressive multifocal leukoencephalopathy (PML), a…



No related posts.